Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $1.73 Million - $2.25 Million
8,371 New
8,371 $1.73 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $806,854 - $923,418
-4,392 Reduced 73.74%
1,564 $328,000
Q1 2023

May 11, 2023

BUY
$191.89 - $259.92 $1.14 Million - $1.55 Million
5,956 New
5,956 $1.2 Million
Q2 2022

Aug 09, 2022

SELL
$204.13 - $302.4 $870,614 - $1.29 Million
-4,265 Reduced 46.26%
4,954 $1.06 Million
Q1 2022

May 09, 2022

BUY
$255.51 - $362.11 $1.08 Million - $1.53 Million
4,219 Added 84.38%
9,219 $2.62 Million
Q4 2021

Feb 10, 2022

BUY
$351.38 - $448.68 $1.76 Million - $2.24 Million
5,000 New
5,000 $1.88 Million
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $428,536 - $527,045
-1,150 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $338,295 - $427,397
1,150 New
1,150 $425,000
Q1 2020

Apr 29, 2020

SELL
$98.9 - $178.34 $203,338 - $366,667
-2,056 Closed
0 $0
Q4 2019

Jan 23, 2020

BUY
$126.05 - $152.76 $259,158 - $314,074
2,056 New
2,056 $314,000
Q3 2019

Oct 16, 2019

SELL
$125.07 - $143.67 $354,948 - $407,735
-2,838 Closed
0 $0
Q2 2019

Jul 10, 2019

BUY
$123.4 - $148.55 $350,209 - $421,584
2,838 New
2,838 $403,000
Q4 2018

Feb 08, 2019

SELL
$105.09 - $137.23 $263,040 - $343,486
-2,503 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$112.11 - $134.54 $11,211 - $13,454
100 Added 4.16%
2,503 $337,000
Q2 2018

Jul 13, 2018

BUY
$102.37 - $117.25 $245,995 - $281,751
2,403 New
2,403 $270,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.55B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.